We would like to inform all participants, speakers, and attendees that the INFECT 2025 event scheduled during November 17-19, 2025 in Singapore has been postponed. The decision has been made to ensure the best possible experience for everyone involved. The new dates will be announced soon and updated on our website. We sincerely appreciate your understanding and continued support.
For any queries, please contact: [email protected]
We are excited to bring you an even bigger and better event!
Please stay tuned for updated details, which will be shared soon.
Mathews Journal of Immunology & Allergy is proud to serve as the supporting journal for this upcoming event on Infectious Diseases. As part of this collaboration, a DOI will be assigned to the conference proceedings book, ensuring the research and findings presented at the event are globally accessible and citable. Additionally, participants who wish to publish their full-length research articles have the opportunity to submit their manuscripts for consideration in the Mathews Journal of Immunology & Allergy. This is an excellent platform for researchers and professionals to share their contributions to the field, receive peer-reviewed recognition, and enhance the visibility of their work. Article processing charges are completely free, and submitted manuscripts will only be published after a thorough peer review by the journal's editorial team.
Mathews Journal of Immunology & Allergy is a scholarly journal of international repute that publishes peer-reviewed research on key topics, such as the immune system, innate and adaptive immunity, antibody response, T and B lymphocytes, anaphylaxis, primary immune deficiencies, infectious disease, occupational and environmental allergy, allergic rhinitis, food allergy, angioedema, asthma, atopic dermatitis, antihistamines, and monoclonal antibody generation.
MJIA publishes high-impact clinical and translational research manuscripts aimed at immunologists, allergists, and medical professionals and researchers interested in studying clinical immunology and allergic diseases and associated mechanisms. The journal publishes clinical trials and mechanistic studies investigating novel therapies and providing insights into the underlying mechanisms, with special focus on discoveries that will enrich our understanding of immune and allergy related diseases that will ultimately improve the diagnosis and management of patients affected by these conditions.
MJIA aims to serve as an international forum for showcasing the work of authoritative medical professionals, researchers, and scientists.
For more details about the journal, visit; https://www.mathewsopenaccess.com/journals/immunology-allergy
To submit your manuscript, please visit: https://www.mathewsopenaccess.com/journals/immunology-allergy/submit-manuscript